Company Filing History:
1 out of 1 
1 out of 3 Years Active: 1977-1991
Title: Ettore Bigatti: Innovator in Steroid Chemistry
Introduction
Ettore Bigatti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of steroid chemistry, holding 2 patents that showcase his innovative approaches to drug development.
Latest Patents
One of his latest patents is titled "Process for the conversion of daunorubicin into doxorubicin." This patent describes an improved method for preparing doxorubicin through the hydrolysis of a doxorubicin ester of a dicarboxylic acid in an acid medium. Another significant patent is "Trimethyl siloxane steroid intermediates," which outlines a procedure for converting steroids with an 11.beta.OH group into potent corticoids. This process involves reacting the 11.beta.-hydroxy steroid with trichloromethyl siloxane steroid, allowing for the incorporation of various substituents into the steroid molecule.
Career Highlights
Ettore Bigatti has worked with several prominent companies in the pharmaceutical industry, including Steroid Development Company Establishment and Sicor Società Italiana Corticosteroidi S.p.A. His work has contributed to advancements in steroid development and therapeutic applications.
Collaborations
Throughout his career, Bigatti has collaborated with notable professionals in the field, including Bjarte Loken and Peter Lindsay MacDonald. These collaborations have further enriched his research and development efforts.
Conclusion
Ettore Bigatti's innovative work in steroid chemistry and his contributions to drug development highlight his importance as an inventor. His patents reflect a commitment to advancing medical science and improving therapeutic options.